Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • AstraZeneca sales and marketing update

    AstraZeneca plc (LSE:AZN; NYSE: AZN), London, U.K. Business: Cancer Germanys Institute for Quality and Efficiency in Health Care (IQWiG) said in an early benefit assessment that added benefit of Tagrisso osimertinib …

    Published on 6/27/2016
  • Collegium sales and marketing update

    Collegium Pharmaceutical Inc. (NASDAQ:COLL), Canton, Mass. Business: Neurology Collegium launched Xtampza ER oxycodone extended-release in the U.S. to manage pain severe enough to require daily, around-the-clock, long-…

    Published on 6/27/2016
  • Eli Lilly sales and marketing update

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Cancer Germanys Institute for Quality and Efficiency in Health Care (IQWiG) said in two early benefit assessments that Cyramza ramucirumab from Lilly has minor …

    Published on 6/27/2016
  • Exelixis, Genentech, Roche sales and marketing update

    Exelixis Inc. (NASDAQ:EXEL), South San Francisco, Calif. Genentech Inc., South San Francisco, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Cancer The U.K.s NICE issued draft guidance recommending …

    Published on 6/27/2016
  • Novartis sales and marketing update

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Cardiovascular Germanys Institute for Quality and Efficiency in Health Care (IQWiG) issued a dossier assessment addendum stating that heart failure drug …

    Published on 6/27/2016
  • Roche, Tib Molbiol sales and marketing update

    Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Tib Molbiol GmbH, Berlin, Germany Business: Diagnostic The companies launched the LightMix Modular Zika Virus Assay to detect the Zika virus in patients living in …

    Published on 6/27/2016
  • Shield Therapeutics sales and marketing update

    Shield Therapeutics plc (LSE:STX), London, U.K. Business: Hematology Shield launched Feraccru ferric maltol in the U.K. to treat adults with iron deficiency anemia associated with inflammatory bowel disease (IBD). The …

    Published on 6/27/2016
  • Theradiag, Miraca sales and marketing update

    Theradiag S.A. (Euronext:ALTER), Marne La Vallee, France Miraca Holdings Inc. (Tokyo:4544), Tokyo, Japan Business: Diagnostic Miracas Miraca Life Sciences subsidiary launched in the U.S. four assays derived from …

    Published on 6/27/2016
  • Vertex sales and marketing update

    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Boston, Mass. Business: Pulmonary The U.K.s NICE issued a final appraisal determination (FAD) recommending against the use of Orkambi lumacaftor/ivacaftor from Vertex to treat …

    Published on 6/27/2016
  • Anika sales and marketing update

    Anika Therapeutics Inc. (NASDAQ:ANIK), Bedford, Mass. Business: Autoimmune Anika launched Cingal in Hungary, Poland, Germany and the Czech Republic to treat pain associated with osteoarthritis. The sodium hyaluronate …

    Published on 6/20/2016
  • Boehringer Ingelheim, Eli Lilly sales and marketing update

    Boehringer Ingelheim GmbH, Ingelheim, Germany Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Endocrine/Metabolic Germanys Institute for Quality and Efficiency in Health Care (IQWiG) said in two separate …

    Published on 6/20/2016
  • Counsyl sales and marketing update

    Counsyl Inc., South San Francisco, Calif. Business: Diagnostic, Cancer Counsyl expanded its Inherited Cancer Screen to test up to 36 genes associated with increased risk for cancer. The test, which uses a small saliva …

    Published on 6/20/2016
  • Protagen sales and marketing update

    Protagen AG, Dortmund, Germany Business: Diagnostic Protagen launched its Multilisa CENP-B, Multilisa Scl-70 and Multilisa BICD2 ELISA assays to diagnose systemic sclerosis. Multilisa CENP-B and Multilisa Scl-70 provide…

    Published on 6/20/2016
  • Teva sales and marketing update

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Neurology Teva recalled all pharmacy-level inventory of migraine drug Zecuity sumatriptan in the U.S. and suspended sales and marketing …

    Published on 6/20/2016
  • Blue Earth Diagnostics, Siemens sales and marketing update

    Blue Earth Diagnostics Ltd., London, U.K. Siemens AG, Munich, Germany Business: Diagnostic Blue Earth and PETNET Solutions Inc. launched Axumin [18F]-fluciclovine injection in the U.S. as a diagnostic PET imaging agent …

    Published on 6/13/2016
  • Curis, Genentech, Roche sales and marketing update

    Curis Inc. (NASDAQ:CRIS), Lexington, Mass. Genentech Inc., South San Francisco, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Cancer Germanys Institute for Quality and Efficiency in Health Care (…

    Published on 6/13/2016
  • Eli Lilly sales and marketing update

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Cancer The U.K.s NICE issued draft guidance recommending against the use of Portrazza necitumumab from Eli Lilly to treat advanced or metastatic, squamous non-…

    Published on 6/13/2016
  • ViiV Healthcare sales and marketing update

    ViiV Healthcare, Brentford, U.K. Business: Infectious ViiV will provide 1.6 million packs of 50 mg Tivicay dolutegravir to the Ministry of Health in Botswana over the next two years as part of the Ministrys Treat All …

    Published on 6/13/2016
  • AIBioTech sales and marketing update

    American International Biotechnology LLC, Richmond, Va. Business: Diagnostic American Internationals Granger Diagnostics division launched Wound~Seq, a next-generation sequencing test to detect bacteria, fungi, …

    Published on 6/6/2016
  • Biocept sales and marketing update

    Biocept Inc. (NASDAQ:BIOC), San Diego, Calif. Business: Diagnostic Biocept launched an expression test for detecting and monitoring PD-L1 expression levels from circulating tumor cells (CTS) from blood samples.

    Published on 6/6/2016
  • Eisai sales and marketing update

    Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Business: Neurology Eisai launched Fycompa perampanel in Japan as an adjunctive therapy for partial-onset seizures or primary generalized tonic-clonic seizures in epileptics …

    Published on 6/6/2016
  • UCB sales and marketing update

    UCB Group (Euronext:UCB), Brussels, Belgium Business: Neurology UCB launched Briviact brivaracetam in the U.S. to treat partial-onset seizures in epileptics ages 16 and older. The high affinity synaptic vesicle protein…

    Published on 6/6/2016
  • 10x Genomics sales and marketing update

    10x Genomics Inc., Pleasanton, Calif. Business: Genomics 10x launched the Chromium System for whole genome or exome sequencing and single-cell analytics. The system runs on the GemCode platform.

    Published on 5/30/2016
  • AstraZeneca, Boehringer Ingelheim, Eli Lilly, J&J, Mitsubishi Tanabe Pharma sales and marketing update

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Boehringer Ingelheim GmbH, Ingelheim, Germany Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Mitsubishi Tanabe Pharma…

    Published on 5/30/2016
  • Cancer Genetics sales and marketing update

    Cancer Genetics Inc. (NASDAQ:CGIX), Rutherford, N.J. Business: Diagnostic Cancer Genetics launched the CLIA-certified CGI Focus::Lymphoma panel for genomic sequencing of B cell lymphomas. The next-generation sequencing…

    Published on 5/30/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993